Extensive studies have focused on understanding the mechanisms of APP trafficking and degradation (3, 4), which are essential for preventing the aberrant accumulation or aggregation of Aβ peptides that are thought to contribute to the development of AD (5, 6, 7). This evidence concerns the gene APP and Alzheimer disease.